Article

Aspheric ablation: good for hyperopic presbyopes

Aspheric ablation is a good surgical option for enhancing near vision in hyperopic presbyopes.

Aspheric ablation is a good surgical option for enhancing near vision in hyperopic presbyopes, according to Marc Lafontaine and colleagues from the Canadian multicentre LASIK trial of aspheric treatments for the correction of hyperopic presbyopia.

A total of 93 hyperopic presbyopic eyes that underwent aspheric ablation were included in the study and used as the basis for predictive factors. Mean preoperative sphere was 1.67 D and the mean cylinder was 0.43 D. Pre- and postoperative subjective questionnaires were handed-out to each subject.

All patients achieved simultaneous 20/25 distance vision and J3 vision at 12-months follow-up. Patient satisfaction was good and spectacle independence was achieved and maintained in more than half of subjects.

Predictive factors of good outcomes include patients requiring glasses for distance vision preoperatively, hyperopic refractive error to appreciate a three line or more improvement and three to six months for neural adaptation to realise the benefit of correction.

The study found that aspheric ablation is a good surgical option for enhancing near vision in hyperopic presbyopes and that patient selection is a key factor in predicting good refractive outcomes and satisfaction.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.